Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company”), a life sciences company developing precision genetic medicines for ...

Dunlavin was alive with the sounds of music and song when the community came together at St Nicholas Church of Ireland for a ...

Health Canada has granted approval for Biogen’s Skyclarys (omaveloxolone) to treat Friedreich’s ataxia (FA), a rare, ...

Biomed Industries, Inc- logo NA-831 for Alzheimer's Disease NA-931 for weight loss Biomed Industries, Inc. CEO to Chair Neuro ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution ...

In addition, I think the recognition across all diseases where not everyone is going to be an expert in FA, and people can refer readily to tertiary care centers and even ordinary care centers that ...

In this video David Lynch, MD, PhD, discusses the effect Friedreich's ataxia can have on patients' quality of life.

Anthony Monaco was a very active teen—involved in soccer, wrestling, and even cross country—but he always felt a little awkward physically. It started with running a little differently than the kids ...